Genome engineering using crispr rna-guided integrases
AssigneeThe Trustees of Columbia University in the City of New York
InventorsPhuc Hong Vo, Samuel Sternberg
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of Columbia University in the City of New York
InventorsPhuc Hong Vo, Samuel Sternberg
Estimating the term…
The present disclosure provides systems and methods for targeted nucleic acid deletions and inactivation of a gene of interest comprising a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated (Cas) (CRISPR-Cas) system comprising at least one Cas protein and a pair of guide RNAs (gRNAs), an engineered transposon system, at least one donor nucleic acid, and a recombinase. The present disclosure also provides methods for genetically modifying diverse bacterial communities comprising contacting a recipient bacterial community with donor bacteria, the donor bacteria comprising a vector encoding: an engineered CRISPR-Cas system, wherein the engineered CRISPR-Cas system comprises: at least one Cas protein and at least one guide RNA (gRNA); an engineered transposon system; at least one donor nucleic acid to be integrated comprising at least one transposon end sequence, and, optionally a recombinase, wherein the donor nucleic acid further comprises a recognitions site for the recombinase.
A system for targeted nucleic acid deletions comprising:
A method for genetically modifying diverse bacterial communities comprising:
Dependencies are inferred from the claim text.